Multiplan Corp (MPLN)

$0.7367

+0.01

(+1.57%)▲

Market is closed - opens 7 PM, 19 Apr 2024

Insights on Multiplan Corp

  • Increasing Revenue

    Revenue is up for the last 4 quarters, 236.59M → 244.13M (in $), with an average increase of 1.0% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -24.14M → -31.39M (in $), with an average decrease of 30.0% per quarter

  • Vs HQY

    In the last 1 year, Healthequity Inc has given 37.0% return, outperforming this stock by 67.3%

  • Vs HQY

    In the last 3 years, Healthequity Inc has given 12.5% return, outperforming this stock by 101.2%

Performance

  • $0.71
    $0.76
    $0.74
    downward going graph

    3.92%

    Downside

    Day's Volatility :7.03%

    Upside

    3.24%

    downward going graph
  • $0.61
    $2.29
    $0.74
    downward going graph

    17.51%

    Downside

    52 Weeks Volatility :73.34%

    Upside

    67.69%

    downward going graph

Returns

PeriodMultiplan CorpSector (Health Care)Index (Russel 2000)
3 Months
-33.46%
-0.7%
0.0%
6 Months
-57.34%
6.6%
0.0%
1 Year
-30.26%
3.7%
-1.5%
3 Years
-88.7%
14.0%
-21.8%

Highlights

Market Capitalization
477.8M
Book Value
$2.64
Earnings Per Share (EPS)
-0.14
Wall Street Target Price
1.68
Profit Margin
-9.54%
Operating Margin TTM
17.19%
Return On Assets TTM
1.48%
Return On Equity TTM
-5.24%
Revenue TTM
961.5M
Revenue Per Share TTM
1.49
Quarterly Revenue Growth YOY
1.3%
Gross Profit TTM
875.6M
EBITDA
590.1M
Diluted Eps TTM
-0.14
Quarterly Earnings Growth YOY
-0.99
EPS Estimate Current Year
-0.19
EPS Estimate Next Year
-0.14
EPS Estimate Current Quarter
-0.05
EPS Estimate Next Quarter
-0.05

Analyst Recommendation

Buy
    75%Buy
    25%Hold
    0
    0%Sell
Based on 8 Wall street analysts offering stock ratings for Multiplan Corp(by analysts ranked 0 to 5 stars)
Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
2
2
2
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 128.04%

Current $0.74
Target $1.68

Company Financials

FY18Y/Y Change
Revenue
1.0B
-
Net Income
36.2M
-
Net Profit Margin
3.48%
-
FY19Y/Y Change
Revenue
982.9M
↓ 5.57%
Net Income
9.7M
↓ 73.19%
Net Profit Margin
0.99%
↓ 2.49%
FY20Y/Y Change
Revenue
937.8M
↓ 4.59%
Net Income
-529.6M
↓ 5554.44%
Net Profit Margin
-56.48%
↓ 57.47%
FY21Y/Y Change
Revenue
1.1B
↑ 19.18%
Net Income
102.1M
↓ 119.27%
Net Profit Margin
9.13%
↑ 65.61%
FY22Y/Y Change
Revenue
1.1B
↓ 3.39%
Net Income
-572.9M
↓ 661.24%
Net Profit Margin
-53.06%
↓ 62.19%
FY23Y/Y Change
Revenue
961.5M
↓ 10.95%
Net Income
-91.7M
↓ 83.99%
Net Profit Margin
-9.54%
↑ 43.52%
Q3 FY22Q/Q Change
Revenue
250.5M
↓ 13.67%
Net Income
19.7M
↑ 46.06%
Net Profit Margin
7.88%
↑ 3.22%
Q4 FY22Q/Q Change
Revenue
241.1M
↓ 3.74%
Net Income
-650.1M
↓ 3394.17%
Net Profit Margin
-269.67%
↓ 277.55%
Q1 FY23Q/Q Change
Revenue
236.6M
↓ 1.86%
Net Income
209.0K
↓ 100.03%
Net Profit Margin
0.09%
↑ 269.76%
Q2 FY23Q/Q Change
Revenue
238.0M
↑ 0.59%
Net Income
-36.4M
↓ 17501.91%
Net Profit Margin
-15.28%
↓ 15.37%
Q3 FY23Q/Q Change
Revenue
242.8M
↑ 2.02%
Net Income
-24.1M
↓ 33.61%
Net Profit Margin
-9.94%
↑ 5.34%
Q4 FY23Q/Q Change
Revenue
244.1M
↑ 0.55%
Net Income
-31.4M
↑ 30.01%
Net Profit Margin
-12.86%
↓ 2.92%
FY19Y/Y Change
Total Assets
8.4B
-
Total Liabilities
6.4B
-
FY20Y/Y Change
Total Assets
8.3B
↓ 0.92%
Total Liabilities
5.7B
↓ 10.75%
FY21Y/Y Change
Total Assets
8.2B
↓ 0.76%
Total Liabilities
5.9B
↑ 3.27%
FY22Y/Y Change
Total Assets
7.4B
↓ 10.33%
Total Liabilities
5.6B
↓ 5.02%
FY23Y/Y Change
Total Assets
7.1B
↓ 3.6%
Total Liabilities
5.4B
↓ 3.3%
Q3 FY22Q/Q Change
Total Assets
8.2B
↓ 0.28%
Total Liabilities
5.8B
↓ 0.89%
Q4 FY22Q/Q Change
Total Assets
8.4B
↑ 2.05%
Total Liabilities
6.4B
↑ 10.77%
Q1 FY23Q/Q Change
Total Assets
7.2B
↓ 13.7%
Total Liabilities
5.4B
↓ 14.87%
Q2 FY23Q/Q Change
Total Assets
7.1B
↓ 1.09%
Total Liabilities
5.4B
↓ 1.09%
Q3 FY23Q/Q Change
Total Assets
7.1B
↓ 1.1%
Total Liabilities
5.3B
↓ 1.11%
Q4 FY23Q/Q Change
Total Assets
7.1B
↑ 0.68%
Total Liabilities
5.4B
↑ 1.66%
FY18Y/Y Change
Operating Cash Flow
292.3M
↓ 20.77%
Investing Cash Flow
-63.6M
↑ 4.69%
Financing Cash Flow
-245.2M
↓ 21.73%
FY19Y/Y Change
Operating Cash Flow
284.3M
↓ 2.73%
Investing Cash Flow
-66.4M
↑ 4.5%
Financing Cash Flow
-201.1M
↓ 17.97%
FY20Y/Y Change
Operating Cash Flow
377.4M
↑ 32.73%
Investing Cash Flow
-210.8M
↑ 217.47%
Financing Cash Flow
-61.6M
↓ 69.37%
FY21Y/Y Change
Operating Cash Flow
404.7M
↑ 7.24%
Investing Cash Flow
-228.4M
↑ 8.32%
Financing Cash Flow
-114.7M
↑ 86.18%
FY22Y/Y Change
Operating Cash Flow
372.4M
↓ 7.99%
Investing Cash Flow
-104.4M
↓ 54.27%
Financing Cash Flow
-115.7M
↑ 0.92%
Q3 FY22Q/Q Change
Operating Cash Flow
109.0M
↑ 167.89%
Investing Cash Flow
-20.8M
↓ 38.69%
Financing Cash Flow
-3.5M
↓ 1.63%
Q4 FY22Q/Q Change
Operating Cash Flow
27.7M
↓ 74.61%
Investing Cash Flow
-25.5M
↑ 22.66%
Financing Cash Flow
-103.4M
↑ 2860.89%
Q1 FY23Q/Q Change
Operating Cash Flow
64.2M
↑ 131.92%
Investing Cash Flow
-23.1M
↓ 9.5%
Financing Cash Flow
-109.4M
↑ 5.81%
Q2 FY23Q/Q Change
Operating Cash Flow
7.7M
↓ 88.03%
Investing Cash Flow
-173.3M
↑ 650.13%
Financing Cash Flow
-10.7M
↓ 90.19%
Q3 FY23Q/Q Change
Operating Cash Flow
72.1M
↑ 838.43%
Investing Cash Flow
-22.1M
↓ 87.27%
Financing Cash Flow
-38.3M
↑ 257.0%

Technicals Summary

Sell

Neutral

Buy

Multiplan Corp is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Multiplan Corp
Multiplan Corp
7.39%
-57.34%
-30.26%
-88.7%
-92.54%
Solventum Corp
Solventum Corp
-10.64%
-10.64%
-10.64%
-10.64%
-10.64%
Veeva Systems Inc.
Veeva Systems Inc.
-12.8%
-3.39%
8.83%
-26.33%
55.83%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
-5.98%
30.6%
1.83%
40.83%
40.83%
Healthequity Inc
Healthequity Inc
-3.72%
6.22%
37.05%
12.91%
23.47%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Multiplan Corp
Multiplan Corp
6.11
NA
NA
-0.19
-0.05
0.01
NA
2.64
Solventum Corp
Solventum Corp
NA
NA
NA
0.0
0.12
0.08
NA
NA
Veeva Systems Inc.
Veeva Systems Inc.
62.03
62.03
1.35
4.76
0.13
0.05
NA
28.8
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
28.08
28.08
20.11
4.3
0.19
0.06
0.0
15.67
Healthequity Inc
Healthequity Inc
125.42
125.42
2.29
2.19
0.03
0.03
NA
23.63
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Multiplan Corp
Multiplan Corp
Buy
$477.8M
-92.54%
6.11
-9.54%
Solventum Corp
Solventum Corp
NA
$11.7B
-10.64%
NA
16.42%
Veeva Systems Inc.
Veeva Systems Inc.
Buy
$32.3B
55.83%
62.03
22.24%
Ge Healthcare Technologies Inc.
Ge Healthcare Technologies Inc.
Buy
$39.0B
40.83%
28.08
8.02%
Healthequity Inc
Healthequity Inc
Buy
$6.9B
23.47%
125.42
5.57%

Institutional Holdings

  • H&F Corporate Investors VIII, Ltd.

    33.45%

  • PUBLIC INVESTMENT FUND

    7.95%

  • LEONARD GREEN PARTNERS LP

    5.97%

  • Vanguard Group Inc

    5.67%

  • BlackRock Inc

    4.15%

  • T. Rowe Price Investment Management,Inc.

    3.77%

Company Information

Organization
Multiplan Corp
Employees
2800
CEO
Mr. Dale A. White
Industry
Finance

Discover More

FAQs